These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 4810909

  • 1. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
    Riley V, Spackman D, Fitzmaurice MA, Roberts J, Holcenberg JS, Dolowy WC.
    Cancer Res; 1974 Feb; 34(2):429-38. PubMed ID: 4810909
    [No Abstract] [Full Text] [Related]

  • 2. Critical influence of an enzyme-elevating virus upon long-term remissions of mouse leukemia following asparaginase therapy.
    Riley V, Spackman DH, Fitzmaurice MA.
    Recent Results Cancer Res; 1970 Feb; 33():81-101. PubMed ID: 4949171
    [No Abstract] [Full Text] [Related]

  • 3. Antineoplastic and toxic effects of Acinetobacter and Pseudomonas glutaminase-asparaginases.
    Schmid FA, Roberts J.
    Cancer Chemother Rep; 1974 Feb; 58(6):829-40. PubMed ID: 4447925
    [No Abstract] [Full Text] [Related]

  • 4. Enhancement of melphalan therapy with glutaminase:asparaginase.
    Vistica DT, Rabon A, Rabinovitz M.
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):83-92. PubMed ID: 725323
    [Abstract] [Full Text] [Related]

  • 5. Influence of a benign virus upon mouse leukemia during asparaginase therapy.
    Riley V.
    Pathol Biol (Paris); 1970 Oct; 18(15):757-64. PubMed ID: 4917552
    [No Abstract] [Full Text] [Related]

  • 6. Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice.
    Vadlamudi S, Krishna B, Reddy VV, Goldin A.
    Cancer Res; 1973 Sep; 33(9):2014-9. PubMed ID: 4725366
    [No Abstract] [Full Text] [Related]

  • 7. Gel entrapped L-asparaginase: kinetic behavior and antitumor activity.
    O'Driscoll KF, Korus RA, Ohnuma T, Walczack IM.
    J Pharmacol Exp Ther; 1975 Nov; 195(2):382-8. PubMed ID: 241845
    [Abstract] [Full Text] [Related]

  • 8. [Biological properties of glutamin-(asparagin-)ase from Pseudomonas boreopolis 526].
    Pekhov AA, Zanin VA, Kozlov AM, Iurchenko AIa, Kondrat'eva NA.
    Biull Eksp Biol Med; 1986 Jul; 102(7):71-4. PubMed ID: 3730598
    [Abstract] [Full Text] [Related]

  • 9. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.
    Nath CE, Dallapozza L, Eslick AE, Misra A, Carr D, Earl JW.
    Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071
    [Abstract] [Full Text] [Related]

  • 10. Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adults.
    Warrell RP, Chou TC, Gordon C, Tan C, Roberts J, Sternberg SS, Philips FS, Young CW.
    Cancer Res; 1980 Dec; 40(12):4546-51. PubMed ID: 7438089
    [Abstract] [Full Text] [Related]

  • 11. Enzyme therapy of cancer, future studies.
    Holcenberg JS.
    Cancer Treat Rep; 1981 Dec; 65 Suppl 4():61-5. PubMed ID: 7346158
    [Abstract] [Full Text] [Related]

  • 12. Role of the LDH-elevating virus in leukemia therapy by asparaginase.
    Riley V.
    Nature; 1968 Dec 21; 220(5173):1245-6. PubMed ID: 5725988
    [No Abstract] [Full Text] [Related]

  • 13. Purification and properties of a highly potent antitumor glutaminase-asparaginase from Pseudomonas 7Z.
    Roberts J.
    J Biol Chem; 1976 Apr 10; 251(7):2119-23. PubMed ID: 5441
    [Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
    Warrell RP, Arlin ZA, Gee TS, Chou TC, Roberts J, Young CW.
    Cancer Treat Rep; 1982 Jul 10; 66(7):1479-85. PubMed ID: 7046929
    [Abstract] [Full Text] [Related]

  • 15. Effect of succinylated Acinetobacter glutaminase-asparaginase treatment on an acute myeloid leukemia in the rat (BNML).
    Sonneveld P, Holcenberg JS, van Bekkum DW.
    Eur J Cancer (1965); 1979 Aug 10; 15(8):1061-3. PubMed ID: 292598
    [No Abstract] [Full Text] [Related]

  • 16. Sensitivity to L-asparaginase and amino acid metabolism.
    Miller HK, Krakoff IH, Salser JS, Balis ME.
    J Natl Cancer Inst; 1970 May 10; 44(5):1129-39. PubMed ID: 5514473
    [No Abstract] [Full Text] [Related]

  • 17. Effect of Acinetobacter glutaminase-asparaginase treatment on free amino acids in mouse tissues.
    Holcenberg JS, Tang E, Dolowy WC.
    Cancer Res; 1975 May 10; 35(5):1320-5. PubMed ID: 1091350
    [Abstract] [Full Text] [Related]

  • 18. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy].
    Nervi C, Casale C, Cortese M.
    Policlinico Prat; 1969 Mar 10; 76(10):297-304. PubMed ID: 5252042
    [No Abstract] [Full Text] [Related]

  • 19. A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases.
    Roberts J, Schmid FA, Old LJ, Stockert E.
    Cancer Biochem Biophys; 1976 May 10; 1(4):175-8. PubMed ID: 788892
    [Abstract] [Full Text] [Related]

  • 20. [Immobilized asparaginase and its use in medicine].
    Kozlov EA, Petriĭ OP.
    Vopr Med Khim; 1978 May 10; 24(6):723-33. PubMed ID: 32657
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.